Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.

Using the 18f-fluoro-2-deoxy-d-glucose technique and positron emission tomography (PET), the local cerebral glucose utilisation (1CMRGlc) was measured in four non-demented patients with early-onset, bilateral Parkinson's disease characterised by the predominance of akinesia. The study was done twice, first in the untreated condition, and then after levodopa had been resumed. Despite a marked clinical improvement, we found no alteration in 1CMRGlc between the first and second studies in any of the brain structure analysed. Compared to control values, 1CMRGlc in the basal ganglia was moderately increased in both studies. These essentially negative findings agree with most previous human or animal studies, and indicate that the functional alterations in the central dopaminergic systems of patients with Parkinson's disease have metabolic correlates that are too small to be demonstrated by current PET devices.

[1]  David E. Kuhl,et al.  Effect of Ischemia on Quantification of Local Cerebral Glucose Metabolic Rate in Man , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Y. Agid,et al.  Dopamine deficiency in the cerebral cortex in Parkinson disease , 1982, Neurology.

[3]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[4]  W. Schwartz A role for the dopaminergic nigrostriatal bundle in the pathogenesis of altered brain glucose consumption after lateral hypothalamic lesions. Evidence using the14C-labeled deoxyglucose technique , 1978, Brain Research.

[5]  E. Hoffman,et al.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.

[6]  J. Mazziotta,et al.  TOMOGRAPHIC MAPPING OF HUMAN CEREBRAL METABOLISM: NORMAL UNSTIMULATED STATE , 1981 .

[7]  E. Hoffman,et al.  Noninvasive determination of local cerebral metabolic rate of glucose in man. , 1980, The American journal of physiology.

[8]  S. Bentin,et al.  Regional cerebral blood flow in patients with Parkinson's disease. , 1979, Archives of neurology.

[9]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[10]  M E Phelps,et al.  ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  John F. Marshall,et al.  Plasticity of [14C]2-deoxy-d-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement , 1980, Brain Research.

[12]  B. C. Motter,et al.  The functional properties of the light-sensitive neurons of the posterior parietal cortex studied in waking monkeys: foveal sparing and opponent vector organization , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  S. Bentin,et al.  Regional cerebral blood flow in parkinsonism Measurement before and after levodopa , 1978, Journal of Neurological Sciences.

[14]  E. Evarts,et al.  Lesions of ascending dopaminergic pathways decrease forebrain glucose uptake , 1976, Nature.

[15]  John F. Marshall,et al.  Recovery of function and basal ganglia [14C]2-deoxyglucose uptake after nigrostriatal injury , 1983, Brain Research.

[16]  J. LaManna,et al.  Abnormalities of cerebral oxidative metabolism in animal models of Parkinson disease , 1982, Neurology.

[17]  J C Mazziotta,et al.  Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.

[18]  R. C. Collins,et al.  Metabolic effects of unilateral lesion of the substantia nigra , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[20]  Fred Dainton Symbionts or parasites? , 1976, Nature.

[21]  Y Yonekura,et al.  Use of 2-Deoxy-D[1-11C]Glucose for the Determination of Local Cerebral Glucose Metabolism in Humans: Variation within and between Subjects , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  J. Baron,et al.  Coupling between regional blood flow and oxygen utilization in the normal human brain. A study with positron tomography and oxygen 15. , 1983, Archives of neurology.

[23]  Y. Agid,et al.  Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa. , 1978, Archives of neurology.

[24]  L. Sokoloff,et al.  Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. , 1981, Federation proceedings.

[25]  C Crouzel,et al.  Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  ONSET AND END-OF-DOSE LEVODOPA-INDUCED DYSKINESIAS , 1978 .

[27]  Helen E. Savaki,et al.  The distribution of alterations in energy metabolism in the rat brain produced by apomorphine , 1982, Brain Research.

[28]  S. R. Snodgrass,et al.  Effects of substantia nigra lesions on forebrain 2-deoxyglucose retention in the rat , 1980, Brain Research.

[29]  O. Lindvall,et al.  Effects of metamphetamine on blood flow in the caudate-putamen after lesions of the nigrostriatal dopaminergic bundle in the rat , 1981, Brain Research.

[30]  P. Dupui,et al.  Cerebral Blood Flow Studied by Xenon-133 Inhalation Technique in Parkinsonism: Loss of Hyperfrontal Pattern , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  L. Brown,et al.  l-DOPA produces regional changes in glucose utilization which form discrete anatomic patterns in motor nuclei and the hypothalamus of rats , 1982, Experimental Neurology.

[32]  P. Gaspar,et al.  Biochemical neuropathology of Parkinson's disease. , 1984, Advances in neurology.

[33]  T. Jones,et al.  Regional impairment of cerebral oxidative metabolism in Parkinson's disease. , 1979, Journal of neurology, neurosurgery, and psychiatry.